Our Leadership Team

David Gilman

Chief Business & Strategy Officer
David Gilman

Mr. Gilman joined ADC Therapeutics in July 2022 and has spent the past 25 years in senior-level business development and strategy positions in life sciences. Prior to ADC Therapeutics, Mr. Gilman was a partner at ClearView Healthcare Partners where he developed a range of portfolio, drug development, investment, transactional and partnering strategies. He has worked in a broad swath of medicine, with a particular focus on oncology and orphan diseases.

Prior to joining Clearview, Mr. Gilman served as Global Head of Portfolio Management, Business Development & Licensing, at Novartis Oncology. Before Novartis, Mr. Gilman spent the majority of his career as a Managing Director of The Frankel Group in NYC and Israel, ultimately serving as Managing Director and lead of Huron’s Life Science Strategy team.

Mr. Gilman holds an AB, with honors, in East Asian History from the University of Chicago and an MBA from the University of Texas at Austin.

Back to Our Leadership Team